BlackRock, Inc. 13D and 13G filings for Cardiovascular Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
BlackRock Inc. BLK |
7,895,902 18.900% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
BlackRock Inc. BLK |
7,895,902 18.900% |
888,638 (+12.68%) |
Filing |
| 2022-01-28 1:54 pm Purchase |
2021-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
BlackRock Inc. BLK |
7,007,264 17.300% |
37,375 (+0.54%) |
Filing |
| 2021-01-25 4:49 pm Purchase |
2020-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
BlackRock Inc. BLK |
6,969,889 17.400% |
1,538,760 (+28.33%) |
Filing |